TTP6.01 Measurement of Lipids in Acute Pancreatitis (Hyperlipidemic Pancreatitis) Joint Surgical and Endocrinology project

Aims This project aims to improve the identification and management of high triglyceride (TG) levels as a contributing factor in acute pancreatitis (AP) cases at a district Hospital. It focuses on addressing gaps in lipid screening, ensuring timely referral to endocrinology or dieticians, and optimizing interventions to reduce recurrence rates and improve outcomes. Methods A retrospective audit was conducted on 78 patients admitted with or diagnosed with AP between March and August 2022. Patient data were reviewed to identify lipid measurement practices, causes of pancreatitis, and referral patterns. Interventions included working with the laboratory to partially automate lipid testing and planning educational initiatives for surgical teams. Results The audit revealed that nearly 31% of cases of pancreatitis had no identifiable cause, with undiagnosed high TG levels likely contributing in a subset. High TG levels (≥10 mmol/L) were linked to increased severity and mortality in AP, aligning with findings from prior studies. The existing system of lipid testing was inconsistent, particularly for cases diagnosed through imaging rather than amylase levels. Implementing lab automation for lipid screening improved testing rates with up to 87% but highlighted the need for continued manual blood requests for CT-diagnosed cases. Conclusions Hypertriglyceridemia is an under-recognized yet significant cause of AP. Consistent lipid testing and timely referrals to endocrinology and dieticians can reduce recurrence and improve outcome. Automation of lipid screening is a valuable step forward, but further education and system adjustments are essential for comprehensive management. Future audits will evaluate the impact of these interventions.